Home » About Us » News » Press Release

Press Releases
New Monoclonal Antibodies for Yellow Fever NS1 - 3/13/2017

 

 
 
 
 
 
  Forward icon  
 
 
 
 
 

 

New Monoclonal Antibodies for Yellow Fever NS1

Yellow Fever is a flavivirus spread by the Aedes aegypti mosquito. It causes acute viral disease that typically requires hospitalization and accounts for 30,000 deaths per year. Since the 1980’s the number of cases of yellow fever have been increasing.

Due to the adaptability of the Aedes aegypti mosquito to high-density urban areas combined with worldwide climate change, recent years have demonstrated that populations are increasingly susceptible to contracting flavivirus infections. Specifically, large epidemics have been shown to occur when infected people introduce the virus into heavily populated areas with high mosquito density and where most people have little or no immunity due to lack of vaccination. A live-virus vaccine has been used for several decades to prevent Yellow Fever.

Yellow Fever NS1
Monoclonal Antibodies

• 
Specific for Yellow Fever Virus NS1 protein
 No cross reaction with other Flavivirus proteins
 Tested for use in ELISA and Lateral Flow
C01906M
C01907M
C01908M
C01909M
C01910M
C01911M
C01912M

> REQUEST MORE INFORMATION

 

 

Meet us at our next conference!

CACLP
Booth #H4-B060
March 12 – 14, 2017
Qingdao, China

> Request a meeting

Medlab Asia 2017
Booth #P31
April 3-5, 2017

Suntec Exhibition & Convention Centre, Singapore

> Request a meeting

 
 

 

 
 
back